NUMD Stock Overview
A medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Nu-Med Plus, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.05 |
| 52 Week High | US$0.09 |
| 52 Week Low | US$0.012 |
| Beta | 0.79 |
| 11 Month Change | -31.03% |
| 3 Month Change | -32.43% |
| 1 Year Change | 156.41% |
| 33 Year Change | -50.00% |
| 5 Year Change | -88.89% |
| Change since IPO | -93.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| NUMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 12.2% | -0.4% | 1.8% |
| 1Y | 156.4% | 21.1% | 31.9% |
Return vs Industry: NUMD exceeded the US Medical Equipment industry which returned 21.7% over the past year.
Return vs Market: NUMD exceeded the US Market which returned 32.8% over the past year.
Price Volatility
| NUMD volatility | |
|---|---|
| NUMD Average Weekly Movement | 29.8% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NUMD's share price has been volatile over the past 3 months.
Volatility Over Time: NUMD's weekly volatility has decreased from 51% to 30% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 2 | Russ Colvin | www.nu-medplus.com |
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. The company develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications, as well as portable delivery system. It serves hospitals, health systems, and the medical community.
Nu-Med Plus, Inc. Fundamentals Summary
| NUMD fundamental statistics | |
|---|---|
| Market cap | US$4.18m |
| Earnings (TTM) | -US$112.11k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-37.3x
P/E RatioIs NUMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NUMD income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$112.11k |
| Earnings | -US$112.11k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0013 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -53.8% |
How did NUMD perform over the long term?
See historical performance and comparison